{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:18:05Z","timestamp":1762175885452,"version":"3.41.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm Gen Sect"],"published-print":{"date-parts":[[1993,2]]},"DOI":"10.1007\/bf02260914","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T02:48:12Z","timestamp":1132714092000},"page":"45-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease"],"prefix":"10.1007","volume":"5","author":[{"given":"H.","family":"Baas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Stecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1993,2,1]]},"reference":[{"key":"BF02260914_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0021-9681(68)90024-6","volume":"21","author":"A Alba","year":"1968","unstructured":"Alba A, Trainor FS, Ritter W, Dacso MM (1968) A clinical disability rating for Parkinson patients. J Chron Dis 21: 507\u2013522","journal-title":"J Chron Dis"},{"key":"BF02260914_CR2","first-page":"221","volume-title":"Vegetativst\u00f6rungen beim Parkinson-Syndrom","author":"H Baas","year":"1984","unstructured":"Baas H, Fischer PA (1984) Salbengesicht. Zentrale Dyregulation der Talgsekretion beim Parkinson-Syndrom. In: Fischer PA (Hrsg) Vegetativst\u00f6rungen beim Parkinson-Syndrom. Editiones Roche, Basel\/Grenzbach, S 221\u2013234"},{"key":"BF02260914_CR3","first-page":"213","volume-title":"Sp\u00e4tsyndrome der Parkinson-Krankheit","author":"H Baas","year":"1986","unstructured":"Baas H, Fischer PA (1986) Fluktuationen der Beweglichkeit beim Parkinson-Syndrom. In: Fischer PA (Hrsg) Sp\u00e4tsyndrome der Parkinson-Krankheit. Editiones Roche, Basel\/Grenzach, S 213\u2013233"},{"key":"BF02260914_CR4","first-page":"257","volume":"202","author":"W Birkmayer","year":"1972","unstructured":"Birkmayer W, Neumayer E (1972) Die moderne medikament\u00f6se Behandlung des Parkinsonismus. Z Neurol 202: 257\u2013280","journal-title":"Z Neurol"},{"key":"BF02260914_CR5","first-page":"491","volume":"61","author":"T Briebach","year":"1990","unstructured":"Briebach T, Baa H, Fischer PA (1990) Orthostatische Regulationsst\u00f6rung beim Parkinson-Syndrom. Nervenarzt 61: 491\u2013494","journal-title":"Nervenarzt"},{"key":"BF02260914_CR6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/archneur.1989.00520450025014","volume":"46","author":"RG Brown","year":"1989","unstructured":"Brown RG, McCarthy B, Jahanshahi M, Marsden CD (1989) Accuracy of self reported disability in patients with parkinsonism. Arch Neurol 46: 955\u2013959","journal-title":"Arch Neurol"},{"key":"BF02260914_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00005053-196108000-00010","volume":"133","author":"GJ Canter","year":"1961","unstructured":"Canter GJ, de la Torre R, Mier M (1961) A method for evaluating disability in patients with Parkinson's disease. Nerv Ment Dis 133: 143\u2013147","journal-title":"Nerv Ment Dis"},{"key":"BF02260914_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/brain\/96.4.815","volume":"96","author":"K Cassell","year":"1973","unstructured":"Cassell K, Shaw K, Stern G (1973) A computerized tracking technique for the assessment of parkinsonian motor disabilities. Brain 96: 815\u2013826","journal-title":"Brain"},{"key":"BF02260914_CR9","first-page":"349","volume":"45","author":"L Cleeves","year":"1986","unstructured":"Cleeves L, Findley LJ, Gresty M (1986) Assessment of rest tremor in Parkinson's disease. Adv Neurol 45: 349\u2013352","journal-title":"Adv Neurol"},{"key":"BF02260914_CR10","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1212\/WNL.33.8.1098","volume":"33","author":"SG Diamond","year":"1983","unstructured":"Diamond SG, Markham CH (1983) Evaluating the evaluations: or how to weight the scale of parkinsonian disability. Neurology 33: 1098\u20131099","journal-title":"Neurology"},{"key":"BF02260914_CR11","first-page":"313","volume-title":"Monoamines, noyeaux gris centraux et syndrome de Parkinson","author":"RC Duvoisin","year":"1970","unstructured":"Duvoisin RC (1970) The evaluation of extrapyramidal disease. In: Ajuriaguerra J (ed) Monoamines, noyeaux gris centraux et syndrome de Parkinson. Masson, Paris, pp 313\u2013325"},{"key":"BF02260914_CR12","first-page":"153","volume-title":"Recent developments in Parkinson's disease","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton RL, UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease. Macmillian Health Care Information, New York, pp 153\u2013164"},{"key":"BF02260914_CR13","first-page":"235","volume":"45","author":"PA Fischer","year":"1986","unstructured":"Fischer PA (1986) Longterm course in Parkinson's syndrome and cerebral polypathy(Parkinson plus). Adv Neurol 45: 235\u2013238","journal-title":"Adv Neurol"},{"key":"BF02260914_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/bmj.292.6519.537","volume":"292","author":"M Forrest","year":"1986","unstructured":"Forrest M, Andersen B (1986) Ordinal scale and statistics in medical research. Br Med J 292: 537\u2013538","journal-title":"Br Med J"},{"key":"BF02260914_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/archpsyc.1977.01770190101010","volume":"34","author":"CM Gaitz","year":"1977","unstructured":"Gaitz CM, Varner RV, Overall JE (1977) Pharmacotherapy for organic brain syndrome in late life. Arch Gen Psychiatry 34: 839\u2013845","journal-title":"Arch Gen Psychiatry"},{"key":"BF02260914_CR16","volume-title":"Das Parkinson-Syndrom","author":"F Gerstenbrand","year":"1986","unstructured":"Gerstenbrand F, Klingler D, Poewe W, Schnaberth G (1986) Pr\u00e4sentation des Dokumentationsbogens f\u00fcr Parkinsonkranke der \u00d6sterreichischen Parkinsongesellschaft. In: Schnaberth G, Auff E (Hrsg) Das Parkinson-Syndrom. Editiones Roche, Wien"},{"key":"BF02260914_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(69)91417-2","volume":"ii","author":"RB Godwin-Austen","year":"1969","unstructured":"Godwin-Austen RB, Tomlinson EB, Frears CC, Kok HWL (1969) Effects of L-Dopa in Parkinson's disease. Lancet ii: 165\u2013168","journal-title":"Lancet"},{"key":"BF02260914_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/jnnp.49.4.381","volume":"49","author":"AM Gotham","year":"1986","unstructured":"Gotham AM, Brown RG, Marsden CD (1986) Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49: 381\u2013389","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02260914_CR19","first-page":"142","volume":"20","author":"HB Hamot","year":"1984","unstructured":"Hamot HB, Patin RJ, Singer MJ (1984) Factur structure of the Sandoz Clinical Assessment Geriatric Scale (SCAG). Psychopharmacol Bull 20: 142\u2013150","journal-title":"Psychopharmacol Bull"},{"key":"BF02260914_CR20","first-page":"136","volume-title":"European Conference on Parkinson's Disease and Extrapyramidal Disorders","author":"M Hely","year":"1990","unstructured":"Hely M, Morris JGL, Wilson A, Fahey P, O'Sullivan DJ, Williamson PM (1990) An evaluation of the Columbia Scale. In: Agnoli A (ed) European Conference on Parkinson's Disease and Extrapyramidal Disorders. John Libbey, Rome London Paris New York, p 136 (Abstract)"},{"key":"BF02260914_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset progression and mortality. Neurology 17: 427\u2013442","journal-title":"Neurology"},{"key":"BF02260914_CR22","volume-title":"Leistungspr\u00fcfsystem (LPS) Handanweisung","author":"W Horn","year":"1983","unstructured":"Horn W (1983) Leistungspr\u00fcfsystem (LPS) Handanweisung, 2. Aufl. Hogrefe, G\u00f6ttingen","edition":"2. Aufl."},{"key":"BF02260914_CR23","first-page":"393","volume":"30","author":"J Jankovic","year":"1980","unstructured":"Jankovic J, Frost JD (1980) Quantitative assessment of parkinsonism and essential tremor: clinical application of triaxial accelerometry. Neurology 30: 393","journal-title":"Neurology"},{"key":"BF02260914_CR24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1212\/WNL.26.6.508","volume":"26","author":"R Kartzinel","year":"1976","unstructured":"Kartzinel R, Calne DB (1976) Studies with bromocriptine. Part 1. On-off phenomena. Neurology 26: 508\u2013510","journal-title":"Neurology"},{"key":"BF02260914_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jnnp.47.3.322","volume":"47","author":"C Kennard","year":"1984","unstructured":"Kennard C, Munro AJ, Park DM (1984) The reliability of clinical assessment of Parkinson's disease. J Neurol Neurosurg Psychiatry 47: 322\u2013323","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02260914_CR26","first-page":"101","volume-title":"Parkinson's disease. Concepts and prospects","author":"JJ Korten","year":"1977","unstructured":"Korten JJ (1977) Correlations in 80 patients with Parkinson's disease. In: Lakke JPWF, Korf J, Wesseling H (eds) Parkinson's disease. Concepts and prospects. Excerpta Medica, Amsterdam, pp 101\u2013110"},{"key":"BF02260914_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0022-510X(81)90109-X","volume":"51","author":"JPWF Lakke","year":"1981","unstructured":"Lakke JPWF (1981) Classification of extrapyramidal disorders. J Neurol Sci 51: 311\u2013327","journal-title":"J Neurol Sci"},{"key":"BF02260914_CR28","first-page":"285","volume-title":"Quantification of neurological deficits","author":"AET Lang","year":"1989","unstructured":"Lang AET, Fahn S (1989) Assessment of Parkinson's disease. In: Munsat T (ed) Quantification of neurological deficits. Butterworth, Boston, pp 285\u2013309"},{"key":"BF02260914_CR29","first-page":"363","volume-title":"Lisuride and other dopamine agonists","author":"TA Larsen","year":"1983","unstructured":"Larsen TA, LeWitt PA, Calne DB (1983) Theoretical and practical issues in assessment of deficits and therapy in parkinsonism. In: Calne DB, Horowski R, McDonald RJ, Wuttke W (eds) Lisuride and other dopamine agonists. Raven Press, New York, pp 363\u2013373"},{"key":"BF02260914_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00002826-198406000-00008","volume":"7","author":"TA Larsen","year":"1984","unstructured":"Larsen TA, Calne S, Calne DB (1984) Assessment of Parkinson's disease. Clin Neuropharmacol 7: 165\u2013169","journal-title":"Clin Neuropharmacol"},{"key":"BF02260914_CR31","first-page":"277","volume-title":"Ergot compounds and brain function. Neuroendocrine and neuropsychiatric aspects","author":"A Liebermann","year":"1980","unstructured":"Liebermann A, Dziatolowski M, Gopinathan G, Kopersmith M, Neophytides A, Korein J (1980) Evaluation of Parkinson's disease. In: Goldstein M (ed) Ergot compounds and brain function. Neuroendocrine and neuropsychiatric aspects. Raven Press, New York, pp 277\u2013286"},{"key":"BF02260914_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/WNL.31.2.125","volume":"31","author":"CH Markham","year":"1981","unstructured":"Markham CH, Diamond SG (1981) Evidence to support early levodopa therapy in Parkinson's disease. Neurology 31: 125\u2013131","journal-title":"Neurology"},{"key":"BF02260914_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2125.1981.tb01118.x","volume":"11","author":"CD Marsden","year":"1981","unstructured":"Marsden CD, Schachter M (1981) Assessment of extrapyramidal disorders. Br J Clin Pharmacol 11: 129\u2013151","journal-title":"Br J Clin Pharmacol"},{"key":"BF02260914_CR34","volume-title":"Parkinson's disease and movement disorders","author":"P Martinez-Martin","year":"1988","unstructured":"Martinez-Martin P, Bermejo-Parejy F (1988) Rating scales in Parkinson's disease. In: Jankovic J, Tolosa E (eds) Parkinson's disease and movement disorders. Urban & Schwarzenberg, Baltimore Munich"},{"key":"BF02260914_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7326\/0003-4819-72-1-29","volume":"72","author":"F Mc Dowell","year":"1970","unstructured":"Mc Dowell F, Lee JE, Swift T, Sweet RD, Ogsbury JS, Tessler JT (1970) Treatment of Parkinson's syndrome with dihydroxyphenylalanine (levodopa). Ann Intern Med 72: 29\u201335","journal-title":"Ann Intern Med"},{"key":"BF02260914_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1212\/WNL.34.4.557-c","volume":"34","author":"GK Montgomery","year":"1984","unstructured":"Montgomery GK (1984) PD and Columbia Scale. Neurology 34: 557\u2013558","journal-title":"Neurology"},{"key":"BF02260914_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00002826-198503000-00009","volume":"8","author":"GK Montgomery","year":"1985","unstructured":"Montgomery GK, Reynolds NC, Warren RM (1985) Qualitative assessment of Parkinson's disease: study of reliability and data reduction with an abbreviated Columbia scale. Clin Neuropharmacol 8: 83\u201392","journal-title":"Clin Neuropharmacol"},{"key":"BF02260914_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0140-6736(70)90634-3","volume":"i","author":"JD Parkes","year":"1970","unstructured":"Parkes JD, Zilkha KJ, Calver DM, Knill-Jones RP (1970a) Controlled trial of amantadine hydrichloride in Parkinson's disease. Lancet i: 259\u2013262","journal-title":"Lancet"},{"key":"BF02260914_CR39","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0140-6736(70)91211-0","volume":"i","author":"JD Parkes","year":"1970","unstructured":"Parkes JD, Zilkha KJ, Marsden CD, Baxter RCH, Knill-Jones RP (1970b) Amantadine dosage in treatment of Parkinson's disease. Lancet i: 1130\u20131133","journal-title":"Lancet"},{"key":"BF02260914_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0021-9681(64)90150-X","volume":"17","author":"L Petrinovich","year":"1964","unstructured":"Petrinovich L, Hardyck C (1964) Behavioural changes in Parkinson patients. A factor analytical study. J Chron Dis 17: 225\u2013233","journal-title":"J Chron Dis"},{"key":"BF02260914_CR41","first-page":"425","volume":"56","author":"AR Potvin","year":"1975","unstructured":"Potvin AR, Tourtelotte WW (1975) The neurological examination: advancements in its quantification. Arch Phys Med Rehabil 56: 425\u2013437","journal-title":"Arch Phys Med Rehabil"},{"key":"BF02260914_CR42","volume-title":"3rd Symposium on Parkinson's Disease","author":"RS Schwab","year":"1969","unstructured":"Schwab RS, England RC (1969) Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson MC (eds) 3rd Symposium on Parkinson's Disease. E. S. Livingstone, Edinburgh"},{"key":"BF02260914_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1532-5415.1974.tb01521.x","volume":"22","author":"RI Shader","year":"1974","unstructured":"Shader RI, Harmatz JS, Salzman C (1974) A new scale for clinical assessment on geriatric populations: SANDOZ Clinical Assessment Geriatric (SCAG). J Am Geriatr Soc 22: 107\u2013113","journal-title":"J Am Geriatr Soc"},{"key":"BF02260914_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/brain\/109.5.845","volume":"109","author":"AE Taylor","year":"1986","unstructured":"Taylor AE, Saint-Cyr JA, Lang AE (1986) Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow. Brain 109: 845\u2013883","journal-title":"Brain"},{"key":"BF02260914_CR45","first-page":"145","volume-title":"Parkinson's disease-current progress, problems and management","author":"H Teravainen","year":"1980","unstructured":"Teravainen H, Calne DB (1980) Quantitative assessment of Parkinsonian deficits. In: Rinne UK, Klinger M, Stamm G (eds) Parkinson's disease-current progress, problems and management. Elsevier, Amsterdam, pp 145\u2013164"},{"key":"BF02260914_CR46","volume-title":"Purdue pegboard. Examiner manual","author":"J Tiffin","year":"1979","unstructured":"Tiffin J (1979) Purdue pegboard. Examiner manual. Lafayette Instruments Company, Reorder Nr. 7-435. Lafayette 2"},{"key":"BF02260914_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0028-3908(73)90079-8","volume":"12","author":"F Velasco","year":"1973","unstructured":"Velasco F, Velasco M (1973) A quantitative evaluation of the effects of L-Dopa on Parkinson's disease. Neuropharmacology 12: 89\u201399","journal-title":"Neuropharmacology"},{"key":"BF02260914_CR48","first-page":"1","volume-title":"Advances in neurology","author":"CD Ward","year":"1983","unstructured":"Ward CD, Sane JN, Dambrosia JM (1983) Methods for evaluating treatment in Parkinson's disease. In Fahn S, Calne DB, Shoulson I (eds) Advances in neurology, vol 37. Raven Press, New York, pp 1\u20137"},{"key":"BF02260914_CR49","first-page":"257","volume":"5","author":"DD Webster","year":"1968","unstructured":"Webster DD (1968) Critical analysis of the disability in Parkinson's disease. Mod Treat 5: 257\u2013282","journal-title":"Mod Treat"},{"key":"BF02260914_CR50","unstructured":"Wiener Determinationsger\u00e4t. Schuhfried Ltd, M\u00f6dling, Austria"},{"key":"BF02260914_CR51","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.1969.00480160015001","volume":"21","author":"MD Yahr","year":"1969","unstructured":"Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM (1969) Treatment of parkinsonism with levodopa. Arch Neurol 21: 343\u2013354","journal-title":"Arch Neurol"},{"key":"BF02260914_CR52","first-page":"915","volume":"20","author":"D v Zerssen","year":"1970","unstructured":"Zerssen v D, Koeller DM, Rey ER (1970) Die Befindlichkeits-Skala. Ein einfaches Instrument zur Objektivierung von Befindlichkeitsst\u00f6rungen, insbesondere im Rahmen von L\u00e4ngsschnittuntersuchungen. Arzneimittelforschung\/Drug Res 20: 915\u2013918","journal-title":"Arzneimittelforschung\/Drug Res"}],"container-title":["Journal of Neural Transmission - Parkinson's Disease and Dementia Section"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02260914\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:02:25Z","timestamp":1750827745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02260914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["BF02260914"],"URL":"https:\/\/doi.org\/10.1007\/bf02260914","relation":{},"ISSN":["0936-3076"],"issn-type":[{"type":"print","value":"0936-3076"}],"subject":[],"published":{"date-parts":[[1993,2]]},"assertion":[{"value":"16 October 1991","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 1992","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 1993","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}